Why Shake Shack, Myriad Genetics, and Trivago Slumped Today
Poor earnings took many stocks lower Tuesday.
Myriad Genetics
MYGN
MYGN
$28.43
-$0.19
-0.7%
BATS BZX Real Time Price as of January 27, 2020, 4:30 p.m. EST
View Interactive MYGN Charts
Myriad Genetics is focused on developing and marketing novel molecular diagnostic products.
News & Analysis: Myriad Genetics
The Fool has written over 200 articles on Myriad Genetics.
Here's Why Myriad Genetics Shares Got Crushed Today
The genetic-testing leader just whacked its fiscal full-year 2020 guidance.
What's Behind Myriad Genetics' Disastrous Q1 Performance
Hardly anything went right for the genetic testing company in its fiscal 2020 Q1.
Myriad Genetics Inc (MYGN) Q1 2020 Earnings Call Transcript
MYGN earnings call for the period ending September 30, 2019.
Here's Why Myriad Genetics Jumped 21.7% in September
The genetic-testing stock can't seem to escape the trap of volatility.
Why Fresh Del Monte Produce, Myriad Genetics, and Jabil Jumped Today
Find out why these stocks held up well on a negative day for the markets.
Here's Why Myriad Genetics Dropped 19.2% in August
The genetic testing leader took investors on a wild ride last month.
3 Cancer Treatment Stocks to Buy Right Now
Cancer is one of the toughest diseases to fight, and these companies are playing a great role in helping people combat it.
Myriad Genetics Limps Into Fiscal 2020
A sluggish end to fiscal 2019 and weaker-than-expected guidance for the year ahead aren't instilling much confidence in investors.
Why Myriad Genetics, Nordstrom, and Luckin Coffee Slumped Today
Different challenges hit these companies but led to the same result.
